CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial evaluating FB825 in adults with atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oneness Biotech Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED